Precigen, Inc. (PGEN) Financial Statements
Precigen, Inc. (PGEN) reported trailing twelve-month revenue of $85.7M (up 146.7% year on year) and net income of -$157.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$115.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PGENPrecigen, Inc.Follow PGEN — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.8 | 71.9 | 173.6 | 190.9 | 231.0 | 151.2 | 90.7 | 32.0 | 14.3 | 26.9 | 6.2 | 3.9 | 9.7 | 85.7 | |
| Gross profit | — | 60.9 | 132.9 | 153.2 | 197.7 | — | — | — | — | — | 0.1 | -0.3 | 4.9 | 77.7 | |
| Research & development | 48.1 | 59.0 | 147.5 | 112.1 | 143.2 | 404.6 | — | — | — | — | 48.6 | 53.1 | 41.3 | — | |
| Operating income | -58.0 | -70.0 | -146.9 | -125.2 | -137.9 | -505.6 | — | — | — | — | -99.8 | -135.0 | -110.5 | -39.5 | |
| Pre-tax income | -39.0 | -85.7 | -87.0 | -194.2 | -78.4 | -395.9 | -171.3 | -104.5 | -111.0 | -80.0 | -96.4 | -128.0 | -250.6 | -157.7 | |
| Income tax | 0.0 | -0.1 | 1.0 | -3.9 | 2.1 | -15.4 | -0.9 | -0.1 | -0.2 | -0.2 | -0.5 | -1.8 | 0.0 | 0.0 | |
| Net income | -39.0 | -81.8 | -84.5 | -186.6 | -117.0 | -509.3 | -322.3 | -170.5 | -92.2 | 28.3 | -95.9 | -126.2 | -250.6 | -157.7 | |
| Diluted EPS ($) | -1.40 | -0.83 | -0.76 | -1.58 | -0.98 | -3.93 | -2.09 | -1.02 | -0.47 | 0.14 | -0.39 | -0.47 | -1.37 | -0.81 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | — | 197.8 | 200.4 | 244.5 | 267.7 | 313.0 | — |
USD millions · SEC XBRL
Precigen, Inc. — questions
- What is Precigen, Inc.'s revenue?
- $85.7M over the twelve months to 2026-06-30, up 146.7% year on year, from its 10-Q and 10-K filings.
- What is Precigen, Inc.'s net income?
- -$157.7M over the twelve months to 2026-06-30.
- What is Precigen, Inc.'s free cash flow?
- -$115.2M over the twelve months to 2026-06-30.
- What are Precigen, Inc.'s diluted earnings per share?
- $-0.81 over the twelve months to 2026-06-30.
Every figure on this page comes from Precigen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.